145 related articles for article (PubMed ID: 27006446)
41. Hypoxic preconditioning: effect, mechanism and clinical implication (Part 1).
Lu GW; Shao G
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2014 Nov; 30(6):489-501. PubMed ID: 26016357
[TBL] [Abstract][Full Text] [Related]
42. Influence of chemical and ischemic preconditioning on cytokine expression after focal brain ischemia.
Pera J; Zawadzka M; Kaminska B; Szczudlik A
J Neurosci Res; 2004 Oct; 78(1):132-40. PubMed ID: 15372497
[TBL] [Abstract][Full Text] [Related]
43. Inhibitory effect of ischemic preconditioning on leukocyte participation in retinal ischemia-reperfusion injury.
Nonaka A; Kiryu J; Tsujikawa A; Yamashiro K; Nishijima K; Miyamoto K; Nishiwaki H; Honda Y; Ogura Y
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2380-5. PubMed ID: 11527953
[TBL] [Abstract][Full Text] [Related]
44. High-Mobility Group Box-1 Modulates the Expression of Inflammatory and Angiogenic Signaling Pathways in Diabetic Retina.
Abu El-Asrar AM; Mohammad G; Nawaz MI; Siddiquei MM
Curr Eye Res; 2015; 40(11):1141-52. PubMed ID: 25495026
[TBL] [Abstract][Full Text] [Related]
45. [Hypoxic preconditioning increases cPKCgamma membrane translocation in murine brain].
Cui XY; Li JF; Han S; Zu PY
Sheng Li Xue Bao; 2004 Aug; 56(4):461-5. PubMed ID: 15322679
[TBL] [Abstract][Full Text] [Related]
46. Differential regulation of cerebral microvascular transcription by single and repetitive hypoxic conditioning.
Harman JC; Otohinoyi DA; Reitnauer JW; Stowe AM; Gidday JM
Cond Med; 2021; 4(1):58-68. PubMed ID: 34414361
[TBL] [Abstract][Full Text] [Related]
47. Effects of hypoxic preconditioning on memory evaluated using the T-maze behavior test.
Kim YH; Lee KS; Kim YS; Kim YH; Kim JH
Anim Cells Syst (Seoul); 2019 Feb; 23(1):10-17. PubMed ID: 30834154
[TBL] [Abstract][Full Text] [Related]
48. Hypoxic preconditioning stimulates angiogenesis in ischemic penumbra after acute cerebral infarction.
Li S; Zhang Y; Shao G; Yang M; Niu J; Lv G; Ji X
Neural Regen Res; 2013 Nov; 8(31):2895-903. PubMed ID: 25206610
[TBL] [Abstract][Full Text] [Related]
49. Engineering CXCL12 Biomimetic Decoy-Integrated Versatile Immunosuppressive Nanoparticle for Ischemic Stroke Therapy with Management of Overactivated Brain Immune Microenvironment.
Shi J; Yang Y; Yin N; Liu C; Zhao Y; Cheng H; Zhou T; Zhang Z; Zhang K
Small Methods; 2022 Jan; 6(1):e2101158. PubMed ID: 35041278
[TBL] [Abstract][Full Text] [Related]
50. Identification and analysis of hub genes and networks related to hypoxia preconditioning in mice (No 035215).
Cheng H; Cui C; Lu S; Xia B; Li X; Xu P; Xue M
Oncotarget; 2018 Feb; 9(15):11889-11904. PubMed ID: 29552280
[TBL] [Abstract][Full Text] [Related]
51. Preconditioning strategy in stem cell transplantation therapy.
Yu SP; Wei Z; Wei L
Transl Stroke Res; 2013 Feb; 4(1):76-88. PubMed ID: 23914259
[TBL] [Abstract][Full Text] [Related]
52. Increased neuronal hypoxic tolerance induced by repetitive chemical hypoxia.
Li H; Liu C; Sun S
J Huazhong Univ Sci Technolog Med Sci; 2002; 22(2):132-4. PubMed ID: 12658755
[TBL] [Abstract][Full Text] [Related]
53. Extending injury- and disease-resistant CNS phenotypes by repetitive epigenetic conditioning.
Gidday JM
Front Neurol; 2015; 6():42. PubMed ID: 25784897
[TBL] [Abstract][Full Text] [Related]
54. The interferon response as a common final pathway for many preconditioning stimuli: unexpected crosstalk between hypoxic adaptation and antiviral defense.
Karuppagounder SS; Zhai Y; Chen Y; He R; Ratan RR
Cond Med; 2018 Apr; 1(4):143-150. PubMed ID: 30198023
[TBL] [Abstract][Full Text] [Related]
55. Correction to "Hypoxic preconditioning improves the survival and neural effects of transplanted mesenchymal stem cells via CXCL12/CXCR4 signalling in a rat model of cerebral infarction".
Cell Biochem Funct; 2024 Jan; 42(1):e3923. PubMed ID: 38269525
[No Abstract] [Full Text] [Related]
56. Epigenetic mechanisms of hypoxic preconditioning.
Rybnikova E; Samoilov M
Springerplus; 2015; 4(Suppl 1):L39. PubMed ID: 27386200
[No Abstract] [Full Text] [Related]
57. Inflammation in stroke--a potential target for neuroprotection?
Priller J; Dirnagl U
Ernst Schering Res Found Workshop; 2002; (39):133-57. PubMed ID: 12066410
[No Abstract] [Full Text] [Related]
58. Heterogeneity of B Cell Functions in Stroke-Related Risk, Prevention, Injury, and Repair.
Selvaraj UM; Poinsatte K; Torres V; Ortega SB; Stowe AM
Neurotherapeutics; 2016 Oct; 13(4):729-747. PubMed ID: 27492770
[TBL] [Abstract][Full Text] [Related]
59. Peripheral VH4+ plasmablasts demonstrate autoreactive B cell expansion toward brain antigens in early multiple sclerosis patients.
Rivas JR; Ireland SJ; Chkheidze R; Rounds WH; Lim J; Johnson J; Ramirez DM; Ligocki AJ; Chen D; Guzman AA; Woodhall M; Wilson PC; Meffre E; White C; Greenberg BM; Waters P; Cowell LG; Stowe AM; Monson NL
Acta Neuropathol; 2017 Jan; 133(1):43-60. PubMed ID: 27730299
[TBL] [Abstract][Full Text] [Related]
60. Research hotspots and frontiers of preconditioning in cerebral ischemia: A bibliometric analysis.
Zhang L; Zhou X; Zhao J; Wang X
Heliyon; 2024 Feb; 10(3):e24757. PubMed ID: 38317957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
